CTOs on the Move

Wright Medical

www.wright.com

 
Wright Medical Group N.V. is a global medical device company focused on providing extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients` lifestyles. The company is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopaedics.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.wright.com
  • 1023 Cherry Road
    Memphis, TN USA 38117
  • Phone: 800.238.7117

Executives

Name Title Contact Details
Tony Lin
Director, cyber security, governance and compliance Profile
Jason Asper
Chief Digital Officer Profile

Funding

Wright Medical raised $675M on 06/22/2018

Similar Companies

MiraVista Behavioral Health Center

MiraVista is a new behavioral health treatment center opening April 2021 in the former Providence Hospital in Holyoke, MA. The newly renovated center will initially provide adult psychiatric and addiction treatment and will expand capacity to include child and adolescent services by the end of the year. Our mission is to provide compassionate, effective, sustainable care for those suffering from psychiatric distress and substance abuse. We are committed to helping fill the critical need for quality behavioral care in the Pioneer Valley and are excited to open our doors this Spring.

BIO- Medical Devices

BIO- Medical Devices is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abramson Cancer Center of the University of Pennsylvania

Abramson Cancer Center of the University of Pennsylvania is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Philcare Home Inc

Philcare Home Inc is a Warminster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eagle Pharmaceuticals

Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.